Skip to main content

Animations

MJFF Publications

6491 - 6500 of 6516 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2024
  • 2021
  • 2022
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: GP2: The Global Parkinson's Genetics Program
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28494
    Citation Count: 163
  • Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology
    2021
    Summary Details
    OPEN
    Title: Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/nan.12728
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Revised criteria for the diagnosis and staging of Alzheimer’s disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-024-02988-7
    Citation Count: 149
  • Summary Details
    OPEN
    Title: Remote smartphone monitoring of Parkinson’s disease and individual response to therapy
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41587-021-00974-9
    Citation Count: 137
  • Summary Details
    OPEN
    Title: Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-022-00643-4
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Mutation of the ALS-/FTD-Associated RNA-Binding Protein FUS Affects Axonal Development
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa, cc-by-nc-sa, cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1523/jneurosci.2148-23.2024
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Chronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.98775
    Citation Count: 5
  • Summary Details
    OPEN
    Title: A Novel MAG Variant Causes Hereditary Spastic Paraplegia in a Consanguineous Pakistani Family
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.3390/genes15091203
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in trans
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.96699
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in trans
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.96699.3
    Citation Count: 9
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.